These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

399 related items for PubMed ID: 17512192

  • 1. Value of complete metabolic response by (18)F-fluorodeoxyglucose-positron emission tomography in oesophageal cancer for prediction of pathologic response and survival after preoperative chemoradiotherapy.
    Kim MK, Ryu JS, Kim SB, Ahn JH, Kim SY, Park SI, Kim YH, Song HY, Shin JH, Jung HY, Lee GH, Choi KD, Cho KJ, Kim JH.
    Eur J Cancer; 2007 Jun; 43(9):1385-91. PubMed ID: 17512192
    [Abstract] [Full Text] [Related]

  • 2. The value of ¹⁸F-FDG PET/CT in assessment of metabolic response in esophageal cancer for prediction of histopathological response and survival after preoperative chemoradiotherapy.
    Myslivecek M, Neoral C, Vrba R, Vomackova K, Cincibuch J, Formanek R, Koranda P, Zapletalova J.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2012 Jun; 156(2):171-9. PubMed ID: 22660205
    [Abstract] [Full Text] [Related]

  • 3. 2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma.
    Swisher SG, Erasmus J, Maish M, Correa AM, Macapinlac H, Ajani JA, Cox JD, Komaki RR, Hong D, Lee HK, Putnam JB, Rice DC, Smythe WR, Thai L, Vaporciyan AA, Walsh GL, Wu TT, Roth JA.
    Cancer; 2004 Oct 15; 101(8):1776-85. PubMed ID: 15386332
    [Abstract] [Full Text] [Related]

  • 4. Fluorine-18 fluorodeoxyglucose positron emission tomography in the preoperative staging of thoracic oesophageal and gastro-oesophageal junction cancer: a prospective study.
    Katsoulis IE, Wong WL, Mattheou AK, Damani N, Chambers J, Livingstone JI.
    Int J Surg; 2007 Dec 15; 5(6):399-403. PubMed ID: 17631431
    [Abstract] [Full Text] [Related]

  • 5. Ineffectiveness of ¹⁸F-fluorodeoxyglucose positron emission tomography in the evaluation of tumor response after completion of neoadjuvant chemoradiation in esophageal cancer.
    Piessen G, Petyt G, Duhamel A, Mirabel X, Huglo D, Mariette C.
    Ann Surg; 2013 Jul 15; 258(1):66-76. PubMed ID: 23470576
    [Abstract] [Full Text] [Related]

  • 6. Prognostic value of metabolic response measured by 18F-FDG-PET in oesophageal cancer patients treated with definitive chemoradiotherapy.
    Onal C, Torun N, Guler OC, Yildirim BA.
    Nucl Med Commun; 2016 Dec 15; 37(12):1282-1289. PubMed ID: 27612030
    [Abstract] [Full Text] [Related]

  • 7. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer.
    Swisher SG, Maish M, Erasmus JJ, Correa AM, Ajani JA, Bresalier R, Komaki R, Macapinlac H, Munden RF, Putnam JB, Rice D, Smythe WR, Vaporciyan AA, Walsh GL, Wu TT, Roth JA.
    Ann Thorac Surg; 2004 Oct 15; 78(4):1152-60; discussion 1152-60. PubMed ID: 15464463
    [Abstract] [Full Text] [Related]

  • 8. 18F-FDG PET Response After Induction Chemotherapy Can Predict Who Will Benefit from Subsequent Esophagectomy After Chemoradiotherapy for Esophageal Adenocarcinoma.
    Xi M, Liao Z, Hofstetter WL, Komaki R, Ho L, Lin SH.
    J Nucl Med; 2017 Nov 15; 58(11):1756-1763. PubMed ID: 28522744
    [Abstract] [Full Text] [Related]

  • 9. Role of surgical resection in complete responders on FDG-PET after chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.
    Jeong Y, Kim JH, Kim SB, Yoon DH, Park SI, Kim YH, Kim HR, Jung HY, Lee GH, Ryu JS.
    J Surg Oncol; 2014 Apr 15; 109(5):472-7. PubMed ID: 24301552
    [Abstract] [Full Text] [Related]

  • 10. FDG-PET status following chemoradiotherapy provides high management impact and powerful prognostic stratification in oesophageal cancer.
    Duong CP, Hicks RJ, Weih L, Drummond E, Leong T, Michael M, Thomas RJ.
    Eur J Nucl Med Mol Imaging; 2006 Jul 15; 33(7):770-8. PubMed ID: 16550384
    [Abstract] [Full Text] [Related]

  • 11. The predictive value of treatment response using FDG PET performed on day 21 of chemoradiotherapy in patients with oesophageal squamous cell carcinoma. A prospective, multicentre study (RTEP3).
    Palie O, Michel P, Ménard JF, Rousseau C, Rio E, Bridji B, Benyoucef A, Meyer ME, Jalali K, Bardet S, M'vondo CM, Olivier P, Faure G, Itti E, Diana C, Houzard C, Mornex F, Di Fiore F, Vera P.
    Eur J Nucl Med Mol Imaging; 2013 Sep 15; 40(9):1345-55. PubMed ID: 23715903
    [Abstract] [Full Text] [Related]

  • 12. The value of 18F-FDG PET before and after induction chemotherapy for the early prediction of a poor pathologic response to subsequent preoperative chemoradiotherapy in oesophageal adenocarcinoma.
    van Rossum PSN, Fried DV, Zhang L, Hofstetter WL, Ho L, Meijer GJ, Carter BW, Court LE, Lin SH.
    Eur J Nucl Med Mol Imaging; 2017 Jan 15; 44(1):71-80. PubMed ID: 27511188
    [Abstract] [Full Text] [Related]

  • 13. Postchemoradiotherapy positron emission tomography predicts pathologic response and survival in patients with esophageal cancer.
    Jayachandran P, Pai RK, Quon A, Graves E, Krakow TE, La T, Loo BW, Koong AC, Chang DT.
    Int J Radiat Oncol Biol Phys; 2012 Oct 01; 84(2):471-7. PubMed ID: 22381904
    [Abstract] [Full Text] [Related]

  • 14. To evaluate the treatment response of locally advanced esophageal cancer after preoperative chemoradiotherapy by FDG-PET/CT scan.
    Huang JW, Yeh HL, Hsu CP, Lu YY, Chuang CY, Lin JC, Lin JF, Chang CF.
    J Chin Med Assoc; 2015 Apr 01; 78(4):229-34. PubMed ID: 25557468
    [Abstract] [Full Text] [Related]

  • 15. Correlation of molecular response as measured by 18-FDG positron emission tomography with outcome after chemoradiotherapy in patients with esophageal carcinoma.
    Konski AA, Cheng JD, Goldberg M, Li T, Maurer A, Yu JQ, Haluszka O, Scott W, Meropol NJ, Cohen SJ, Freedman G, Weiner LM.
    Int J Radiat Oncol Biol Phys; 2007 Oct 01; 69(2):358-63. PubMed ID: 17532577
    [Abstract] [Full Text] [Related]

  • 16. Predictive value of 18-fluoro-deoxy-glucose-positron emission tomography (18F-FDG-PET) in the identification of responders to chemoradiation therapy for the treatment of locally advanced esophageal cancer.
    Levine EA, Farmer MR, Clark P, Mishra G, Ho C, Geisinger KR, Melin SA, Lovato J, Oaks T, Blackstock AW.
    Ann Surg; 2006 Apr 01; 243(4):472-8. PubMed ID: 16552197
    [Abstract] [Full Text] [Related]

  • 17. The role of qualitative and quantitative analysis of F18-FDG positron emission tomography in predicting pathologic response following chemoradiotherapy in patients with esophageal carcinoma.
    Klayton T, Li T, Yu JQ, Keller L, Cheng J, Cohen SJ, Meropol NJ, Scott W, Xu-Welliver M, Konski A.
    J Gastrointest Cancer; 2012 Dec 01; 43(4):612-8. PubMed ID: 22777832
    [Abstract] [Full Text] [Related]

  • 18. Prediction of response to definitive chemoradiotherapy in esophageal cancer using positron emission tomography.
    Kato H, Fukuchi M, Miyazaki T, Nakajima M, Tanaka N, Inose T, Kimura H, Faried A, Saito K, Sohda M, Fukai Y, Masuda N, Manda R, Ojima H, Tsukada K, Oriuchi N, Endo K, Nonaka T, Shioya M, Ishikawa H, Sakurai H, Nakano T, Kuwano H.
    Anticancer Res; 2007 Dec 01; 27(4C):2627-33. PubMed ID: 17695425
    [Abstract] [Full Text] [Related]

  • 19. Utility of 18F-FDG PET for Predicting Histopathologic Response in Esophageal Carcinoma following Chemoradiation.
    Arnett ALH, Merrell KW, Macintosh EM, James SE, Nathan MA, Shen KR, Ravi K, Neben Wittich MA, Haddock MG, Hallemeier CL.
    J Thorac Oncol; 2017 Jan 01; 12(1):121-128. PubMed ID: 27569732
    [Abstract] [Full Text] [Related]

  • 20. 18F-FDG PET in patients with esophageal squamous cell carcinoma undergoing curative surgery: prognostic implications.
    Choi JY, Jang HJ, Shim YM, Kim K, Lee KS, Lee KH, Choi Y, Choe YS, Kim BT.
    J Nucl Med; 2004 Nov 01; 45(11):1843-50. PubMed ID: 15534053
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.